Africa bears the heaviest burden of antimicrobial resistance, a phenomenon fuelled largely by poverty, But there are encouraging signs that the continent is taking action to fight it.
Academic rigor, journalistic flair
Articles on AMR
Displaying 1 - 20 of 26 articles
Antimicrobial resistance is an epidemic that kills close to 5 million people annually. The solutions are complex and must take into account the needs of the poor.
Researchers are desperately seeking viable alternatives to antibiotics. So what is phage therapy? And how could it help?
Drug-resistant microbes are a serious threat for future pandemics, but the new draft of the WHO’s international pandemic agreement may not include provisions for antimicrobial resistance.
Wastewater treatment plants receive wastewater from a variety of sources. This makes them useful proxies for determining the burden of antimicrobial resistance in communities.
Through the choice of images in publications, women and children of colour in low and middle income countries were treated with less dignity and respect than those in high income countries.
A Pandoravirus has been revived after remaining dormant in the Siberian permafrost for nearly 50,000 years.
Hospitals are more risky than farms when it comes to the spread of the Klebsiella superbug.
India’s drug regulation is loose and results in dangerous medicines being sold at home and abroad.
Nearly three-quarters of all patients in the study were taking at least one antibiotic. This is high and could indicate overuse.
The quest to find treatment for COVID-19, and the uncertainty surrounding the clinical outcome, necessitates the use of antibiotics in the treatment package.
Antimicrobial resistance kills around 700,000 people worldwide annually. It is a top-ten global health threat.
A new network of public clinical trials institutes is urgently needed to replenish the empty pipeline for new antibiotics.
A genetic trick called an integron plays an important role in helping bacteria do this.
How resistance to drugs originates, and why it’s different for vaccines.
The African continent has the highest burden of gonorrhoea worldwide. In South Africa alone, it’s estimated that more than 2 million new cases occur annually.
Scientists at Cambridge are developing a lab-in-a-briefcase for rapidly and cheaply identifying disease-causing bacteria.
As antimicrobial resistance increases, the options for treating serious infections dwindle. Doctors need reliable information about which treatments to try out.
Half of all patients who died of COVID-19 in Wuhan had a secondary infection.
A new report estimates that by 2050, 40 per cent of all infections will be resistant to antimicrobial treatment. This will directly cause 13,700 previously preventable deaths.
Top contributors
-
Postdoctoral Researcher, Microbiology, University of Oxford
-
Science Communication Researcher, Stellenbosch University
-
Professor of Public Health, Newcastle University
-
Professor of Global Health, University of Oxford
-
Senior Research Fellow, School of Medicine, The University of Western Australia
-
NHMRC Emerging Leadership Fellow, The University of Western Australia
-
Epidemiologist, Oxford University Clinical Research Unit (OUCRU)
-
Professor of Infectious Diseases, University of Cape Town
-
Professor of Microbial Evolution at The Milner Centre for Evolution, University of Bath
-
Professor of Biochemistry and Biomedical Sciences, McMaster University
-
Professor of Psychology, University of Leicester
-
Professor of Molecular Microbiology, University of Birmingham
-
Research Fellow, University of Oxford
-
Extraordinary Professor in the Department of Medical Microbiology, University of Pretoria
-
Extraordinary Senior Lecture in the Department of Global Health, Stellenbosch University
